Inglewood Independent
In the Inglewood Independent, Evie W. emphasizes that bringing Most Favored Nation drug pricing to American patients is a flawed approach that ignores foreign trade-offs like narrower coverage and delayed access, while threatening to undermine the research pipeline without guaranteeing lower pharmacy counter costs. Instead, Evie advocates for Congress to focus on domestic reforms, specifically enacting real pharmacy benefit manager transparency and reform to ensure negotiated rebates are actually passed down to families rather than being pocketed by middlemen.